Osteoporosis screening in an outpatient liver transplant clinic: impact of primary immunosuppression

Transplant Proc. 2002 Aug;34(5):1569-70. doi: 10.1016/s0041-1345(02)03026-9.

Authors

G A Smallwood¹, J M Wickman, E Martinez, A C Stieber, T G Heffron

Affiliation

¹ Department of Pharmacy, Emory University Hospital Pharmacy, EG #22, 1364 Clifton Road NE, Atlanta, GA 30322, USA.

PMID: 12176489
DOI: 10.1016/s0041-1345(02)03026-9

No abstract available

MeSH terms

Adrenal Cortex Hormones / adverse effects
Bone Density / drug effects
Humans
Immunosuppression Therapy / adverse effects*
Immunosuppressive Agents / adverse effects
Liver Transplantation / immunology*
Mass Screening
Mycophenolic Acid / adverse effects
Mycophenolic Acid / analogs & derivatives
Osteoporosis / chemically induced
Osteoporosis / epidemiology*
Osteoporosis / immunology
Outpatient Clinics, Hospital

Substances

Adrenal Cortex Hormones
Immunosuppressive Agents
Mycophenolic Acid